A man was given spironolactone and other drugs intermittently for control of hypertension. He developed gynecomastia bilaterally; spironolactone was stopped. Three years later, fatal infiltrating ductal adenocarcinoma of the breast supervened. This sequence of events raises suspicion that spironolactone therapy led to lethal breast carcinoma.

(C) Lippincott-Raven Publishers.